Sorafenib In Combination With Paclitaxel As A First-Line Therapy In Patients With Locally Recurrent Or Metastatic Breast Cancer: Overall Survival Results From A Double-Blind, Randomized, Placebo-Controlled, Phase 2b Trial
CANCER RESEARCH（2010）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined